ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
V2ACT Therapeutics Announces IND for V2ACT Study for Pancreatic Cancer americanpharmaceuticalreview
January 05, 2021V2ACT Therapeutics? has obtained permission from the U.S. Food and Drug Administration (FDA) on an Investigational New Drug (IND) application and may proceed with the clinical investigation of V2ACT in a Phase 1/2a trial for the treatment of newly ...
Pharma Sources Insight January 2025
